SARS vaccine: Preliminary Phase I data

Preliminary 56-day data from a double-blind, placebo-controlled, Chinese Phase I trial in

Read the full 128 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE